SCHEMBL9595142

SCHEMBL9595142

Cc1ccc2c(Cl)c3cc(C)ccc3nc2c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
NQO2 P16083 1/20 0.48
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 1/20 0.47
MAOA P21397 2/20 0.47
MAOB P27338 1/20 0.47
PKM P14618 1/20 0.47
ELANE P08246 1/20 0.43
RAD52 P43351 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ACHE P22303 7/20 0.41
BCHE P06276 5/20 0.41
GRIN1 Q05586 5/20 0.41
GRIN2A Q12879 5/20 0.41
DHODH Q02127 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9593290 0.92 LMNA (0.62) LMNANQO2KDM4EALDH1A1MAPT
SCHEMBL9595057 0.92 NQO2 (0.50) LMNANQO2KDM4EALDH1A1MAPT
SCHEMBL22791812 0.91 LMNA (0.50) LMNAKDM4EALDH1A1MAPTMAOA
SCHEMBL27961718 0.87 MAOA (0.67) LMNANQO2KDM4EALDH1A1MAPT
SCHEMBL9593514 0.87 MAOA (0.67) LMNANQO2KDM4EALDH1A1MAPT
SCHEMBL9593843 0.87 LMNA (0.53) LMNANQO2KDM4EALDH1A1MAPT
SCHEMBL9594512 0.85 KDM4E (0.49) LMNANQO2KDM4EALDH1A1PKM
SCHEMBL26356180 0.85 KDM4E (0.52) LMNANQO2KDM4EALDH1A1PKM
SCHEMBL15397410 0.81 MPO (0.45) LMNANQO2KDM4EALDH1A1MAPT
SCHEMBL9594424 0.81 LMNA (0.47) LMNANQO2KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 WO claimed
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 WO disclosed